New pen aims to make haemophilia treatment easier to use
NCT ID NCT05681845
Summary
This study tested whether a new, easier-to-use pen injector delivers the same amount of the haemophilia A treatment Mim8 into the blood as a traditional syringe. It involved 205 healthy men who received one injection under the skin. The goal is to make treatment administration simpler for patients who need it regularly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Campus Charité Mitte - Charité Research Organisation GmbH
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.